Preventing HIV: Rutgers Experts Raise Awareness of Treatment

People at risk for contracting HIV from HIV-positive sexual partners or through intravenous drug use can reduce their risk of infection by up to 90 percent when they take a daily pill as directed.

Pre-exposure prophylaxis (PrEP), which is sold under the name Truvada, is an antiretroviral medication that health authorities call essential to ending the AIDS epidemic. But obstacles such as lack of education, access to health care and insurance, and stigma are often barriers to those who need the treatment the most.

On Dec. 7, the Rutgers School of Public Health and the Rutgers School of Nursing …read more

Source: Rutgers Today

(Visited 8 times, 1 visits today)

Site Footer

Sliding Sidebar